New therapies for the treatment of rare and genetic diseases
Orphazyme has raised €34M across 3 funding rounds from 4 investors, most recently a Series B round in Jan 2015. Based in Copenhagen, Denmark; founded 2009; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2015-01-01 | Series B | €20M | Aescap,IDInvest Partners,Sunstone Capital | View deal → |
| 2011-09-01 | Series A | €14M | Aescap,Novo Ventures,Sunstone Capital | View deal → |
| 2011-02-01 | Seed | €0 | Novo Ventures,Sunstone Capital | View deal → |
